Cogent Biosciences Is Maintained at Buy by Citigroup
Citi Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $15
Analysts Conflicted on These Healthcare Names: American Well (AMWL), Cogent Biosciences (COGT) and NeoGenomics (NEO)
Cogent Biosciences Analyst Ratings
Baird Maintains Neutral on Cogent Biosciences, Raises Price Target to $10
A Quick Look at Today's Ratings for Cogent Biosciences(COGT.US), With a Forecast Between $13 to $22
Hold Rating on Cogent Biosciences Amid Competitive Landscape and Anticipated Milestones
Cogent Biosciences Price Target Cut to $19.00/Share From $22.00 by JP Morgan
Cogent Biosciences Analyst Ratings
5Needham Reiterates Buy on Cogent Biosciences, Maintains $18 Price Target
Cogent Biosciences Garners Buy Rating Amid Promising Clinical Trials and Strategic Growth Potential
LifeSci Capital Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $16
Cogent Biosciences Analyst Ratings
Needham Reiterates Buy on Cogent Biosciences, Maintains $18 Price Target
Cogent Biosciences Analyst Ratings
Needham Reiterates Buy on Cogent Biosciences, Maintains $18 Price Target
Cogent Biosciences Analyst Ratings
Wedbush Reiterates Neutral on Cogent Biosciences, Maintains $10 Price Target
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardelyx (ARDX), Cogent Biosciences (COGT) and Immunocore Holdings (IMCR)
Piper Sandler Sticks to Their Buy Rating for Cogent Biosciences (COGT)